Debby is a writer and editor with more than 20 years of experience. She currently writes and edits reports, journal manuscripts, peer-review summary statements, Web content, and patient-education materials, primarily in the medical field.

She has worked on documents in such diverse medical fields as cancer (including breast, pancreatic, prostate, gynecologic, and brain), diabetes, cardiovascular disease, epidemiology, health services research, hematologic disease, mental illness, organ transplant, and substance abuse.

Debby holds a B.A. from the University of Western Ontario and a Ph.D. in philosophy from Brown University.

Roshawn is a healthcare-policy executive with experience from the perspective of the patient, provider, and manufacturer. Roshawn spent many years at Amgen in strategic-marketing roles of increasing responsibility. Her final role was as a director in Amgen's Washington, DC, global government affairs office.

Roshawn was responsible for strategy for the Centers for Medicare and Medicaid Services across Amgen's oncology portfolio. She also worked in Amgen's strategic planning, analysis, pricing, and reimbursement departments.

She has held the position of Global Director, Health Economics and Reimbursement in the cardiology franchise of Johnson and Johnson, where her team was responsible for health-economics analysis and reimbursement strategy for 20 countries.

As Vice President of Strategy, Planning and Communication at Long Beach Memorial Medical Center and Miller Children's Hospital, the largest private hospital system west of the Mississippi River, Roshawn held responsibility for business development, marketing, and physician partnerships.

She was a management consultant at The Boston Consulting Group, and is a lecturer on healthcare policy.

Roshawn graduated from Northwestern University's Kellogg Graduate School of Management. She has a degree in international and public affairs from the Woodrow Wilson School at Princeton University.

Paloma comes to 1798 Consultants with an extensive legal background, having been a practicing attorney for twenty years.  With a breadth of experience from litigating in courtrooms to speaking at town hall meetings, Paloma's passion for the United States Constitution is evident throughout her work.  Areas of particular emphasis include the foundations and applications of civil liberties, such as the privacy of patient medical records. 

Paloma is a recent author of a major White Paper on the impending Office of Civil Rights HIPAA compliance audits that is being touted as "seminal" in the field.

Paloma also teaches in the field of American politics at the Rochester Institute of Technology. 

Paloma's undergraduate studies in political science and economic theory were undertaken at Wheaton College (MA), where she received her Bachelor of Arts, magna cum laude.  Paloma was elected by her college faculty to Phi Beta Kappa, an academic honor given to less than 1% of college graduates nationwide.  Paloma earned her Juris Doctor at SUNY Buffalo, and was admitted to practice law in New York in 1992.

Liz joined 1798 Consultants after spending 17 years in the healthcare industry at a variety of pharmaceutical and biotechnology companies, as well as a healthcare consulting company.

Liz was Director of Commercial Information and Sales Operations at Genentech. In this role, she led a team that provided sales, marketing, and reimbursement reporting and analysis to the commercial organization. She and her team supported multiple product launches, brand-performance reporting across products, and the development of new capabilities to support expanded commercial reporting and analytics.

Prior to joining Genentech, Liz worked at Amgen in a variety of roles in marketing, information management, and sales operations and analysis. In Sales Operations, she led a team that supported sales reporting and analysis, customer targeting and segmentation, incentive compensation, sales force sizing and structure, and sales force automation.  She also led the definition and implementation of launch tactics to support the launch of Aranesp® (darbepoetin alpha). In marketing, Liz drove the development of the Aranesp 3-year brand plan and lifecycle plan, developed and implemented a new patient-based forecast model, identified key brand-performance indicators and metrics to measure brand performance, and led the implementation of a medical-information call center.

Prior to her work at Amgen, Liz spent more than 7 years at Muro Pharmaceutical in several positions. Her last position at Muro was head of sales and marketing operations and analysis.

Liz received her B.S. from the University of Massachusetts, Amherst. She also received a certificate in executive development from the Kellogg School of Management.

Andrew joined 1798 Consultants after spending 21 years in the healthcare industry at a variety of the largest and most successful pharmaceutical and biotechnology companies.

Prior to joining 1798 Consultants, Andrew served as Vical's Vice President of Corporate Development.  During his tenure, Vical completed distribution agreements for Vical's most advanced program, Allovectin®.

Prior to joining Vical, Andrew served as the Senior Director of Strategy at Biogen Idec, following a two-year assignment overseeing the commercial development of Zevalin®, the first radioimmunotherapy product approved for use in the United States.

Before joining Biogen Idec, Andrew spent the prior year at MedImmune, where he directed marketing efforts for the FluMist® inhaled influenza vaccine.

Andrew has also served in a variety of marketing positions at the world's largest biotechnology company, Amgen.  During his tenure at Amgen, Andrew helped contribute to the success of Enbrel®, Aranesp®, and Epogen®.

Andrew began his career helping to launch TAP Pharmaceuticals' blockbusters Lupron® and Prevacid®.  Andrew earned a bachelor of science degree in engineering from the United States Military Academy at West Point.

Matthew is a business development professional with ten years of experience in sales, marketing, and client relations.

Prior to joining 1798 Consultants, Matthew was responsible for new account acquisition, marketing communications and strategy, public relations, and existing client management at The Aequitas Group, a biopharmaceutical reimbursement and commercialization consultancy.

In addition, Matthew was the lead developer for the World Hospital Monitor strategic initiative. Leveraging this experience, Matthew provides a unique perspective on the development of the healthcare industry in the United States and competing global alternatives.

Prior to joining The Aequitas Group, Matthew co-founded Medical Tourism Solutions, a medical tourism intermediary offering affordable surgical care overseas. In this role, he cultivated relationships with surgeons, hospitals, government agencies, and logistical support personnel to deliver high-quality medical and support services to international clients.

Matthew completed his M.B.A. at the University of California, San Diego, Rady School of Management. He received his B.A. in economics from Willamette University.

Kurt Hartman is a results-driven healthcare industry executive who has a notable track record for building and leading corporate divisions-principally Legal Operations, Compliance, and Access. Prior to joining 1798 Consultants, Kurt held key executive leadership positions, including General Counsel, Chief Compliance Officer, and Senior Vice President, Access at Optimer Pharmaceuticals.

Before he joined Optimer, Kurt demonstrated success in devising strategic programs to increase access and value, decrease costs, and maximize profitability at world-class bio-pharmaceutical companies including Eisai (where he served as Executive Director of Value and Access), Roche Laboratories (where he was the Director of Patient Reimbursement Support and Assistance) and Amgen (where he helped lead Nephrology National Account Sales).  He has substantial expertise in establishing contracting and pricing strategies, incorporating reimbursement support services, positioning drugs for coverage, commercializing products, and interpreting the impact of reimbursement/competitive marketplace dynamics to the bottom-line.

Kurt earned his juris doctor degree at Pepperdine University School of Law (1998) and holds a bachelor of arts in Anthropology from the University of California at Los Angeles (1995). He is admitted to the State Bar of California and has been published in Hospital Physician (March 1999) and Cornell Journal of Law & Public Policy (1999).

Bill joined The 1798 Consultants after spending 22 years at Novartis, Amgen and Allergan in functions that spanned from selling pharmaceuticals to developing access strategies for biologics and devices.  Most recently, Bill was Director of Medical Benefit Marketing at Allergan. In this role, he led a team that created strategy, tactics and tools to support optimal policy language in the Allergan injectable/device portfolio. Bill and his team supported both payor and provider reimbursement initiatives, multiple product and label expansion launches, brand-planning and competitive offense against new toxin approvals. Additionally, Bill worked directly with the State Government Affairs team, Healthcare Policy team and external employer consultants to expand coverage to bariatric surgery.
 
Prior to joining Allergan, Bill worked at Amgen as a Medicare Account Specialist in the Midwest, Payor Marketing Manager to the Medicare team and finally as the Director of Value Access to the Aranesp Oncology franchise.   Bill led the efforts with Global Health Economics to shore up the Aranesp value proposition to mitigate the ESA market decline and co-authored two abstracts on the role of supportive care in "The Working Cancer Patient."  Bill also initiated and led the re-branding and automization efforts of the Amgen reimbursement support services to the current "Amgen Assist" offering.  Preceding Amgen, Bill had a distinguished sales career at Novartis, that included launching unprecedented technology, Apligraf, in the Southwest and laying the groundwork for commercialization in the Latin American market.
 
Bill received his BS at Colorado State University.  Bill also received a certificate in executive development from the Kellogg School of Management.

Janyce brings strong experience in policy and program implementation.  Janyce spent 4 years at Amgen,  specialized in policy analysis, reimbursement training, and landscape analysis for new product launches, followed by 6 years in reimbursement and patient assistance hotline management.  Currently, Janyce has been busy identifying practical impacts of healthcare reform policy and action steps for biotech/pharma  as well as hospital and large systems. 

Prior to healthcare, Janyce served as a Senior Policy Analyst in public administration, where she managed legislative activity, inter-governmental relations and innovation projects.  Her work has resulted in model programs.  Several of these programs garnered state, national and international awards and are still in use today.

Janyce graduated magna cum laude from California Lutheran University, with distinguished department honors.  She is a certified PMP and utilizes project management approaches to identify and implement broad policy initiatives. 

As a part-time consultant, Jim brings over 20 years of pharmaceutical experience with Amgen with the last ten years evaluating different aspects of reimbursement, payment policy, pricing and contracting, and patient assistance.  For the past three years, as Director of Pricing and Contracting, Jim focused on Sarbannes-Oaxley (SOX) compliance for discount accruals and estimating the impacts of Patient Protection Affordable Care Act (PPACA) individually by product and collectively for all government pricing programs.  He also participated in government price reporting and forecasting of ASP for Amgen.
 
In addition, Jim was previously President of The Safety Net Foundation and the ENcourage Foundation, two Amgen sponsored free drug foundations, from 2006 through 2008.  In this role, Jim re-engineered the business process while improving patient care and realizing significant operational savings.
 
Jim is currently a board member of the local chapter of The Wellness Community, a cancer support organization that provides services to patients, care givers, family members and children.
 
Jim has a Ph.D. in Mineral Economics from the Colorado School of Mines, a MBA in Statistics and Operations Research from University of Denver, and a BA from the University of Rochester in Economics and Statistics.

Mary Roberts is a strategic commercial leader skilled at growing brand profitability and leading successful sales, marketing and access initiatives in the healthcare industry.

Mary has fifteen years of experience in developing comprehensive reimbursement strategies and tactics across multiple therapeutic areas and settings of care to drive sales at launch and throughout a product's lifecycle. In fact, she has led or held a position of authority and responsibility for the development of seven product launch strategies across Oncology, Rheumatoid Arthritis, Multiple Sclerosis, Osteoporosis, Chronic Kidney Disease, Metabolic Disease, and Epilepsy.

At Eisai, Inc., Mary held various positions including Northeast Regional Business Director for the Neurology Sales team. She began her career at Eisai within the Managed Markets group as the Director of Market Access and Reimbursement Services, where she had management oversight for Eisai's Patient Assistance Programs, Reimbursement Hotline Support Programs, Drug Replacement Programs, and Co-Pay Support Programs. She was also responsible for leading a team of National Account Reimbursement Managers (NARMs) which support patient access by providing field based reimbursement support for Medicare Contractors, State Medicaid agencies, State Societies and private payors.

Prior to Eisai, Mary worked as a Reimbursement Manager at Roche and as a Managed Markets Consultant at Campbell Alliance Group, Inc. She has also held several reimbursement operations positions at Biogen in Cambridge, MA.

Mary holds a Master of Public Health in Health Services from Boston University and a Bachelor of Science in Biology from Boston College.

Kimberly York is a medical writer and editor with fifteen years of experience developing deliverables for several of America's most admired bio-pharmaceutical companies, including Actavis, Amgen, Amylin, Eisai Pharmaceuticals, Gilead Sciences and Pfizer.  Kimberly has built a diverse portfolio of work that consists of managed markets, marketing, sales training and physician education materials.  Prior to working for 1798 Consultants, she worked in Commercial Operations at Santarus, where she managed the Legal-Medical-Regulatory review process for the copy approval of all external communications and worked closely with Marketing in the drafting and editing of deliverables to support the company's thought-leader Speaker's Bureau. Kimberly also worked for Merck as a Professional Sales Representative in Los Angeles, where she called on cardiologists, internists, and gastroenterologists and helped launch several blockbuster drugs during her tenure.

Kimberly has forged long-term collaborative relationships with hospital Pharmacy Directors, major medical plan Pharmacy Directors, former Medicare Directors and physician thought leaders and has conducted hundreds of market research interviews to help inform client's launch and pricing decisions. She earned a Bachelor's degree in Chemistry from Emory University and a Master's degree in English from the University of California at Riverside.

MBA, Fordham University | B.S., Pharmacy, Rutgers College of Pharmacy

Ilias has more than 17 years of experience in the pharmaceutical industry. He has deep expertise in the areas of patient services, patient assistance programs, commercial strategy, pricing, contracting, risk management, and pharmacy operations.

Ilias has worked for a number of pharmaceutical manufacturers, focusing his career in managed markets and market access. Most recently, he worked at Novartis, where he was the Head of Patient Services Strategy, responsible for developing the patient support programs for all of Novartis' complex specialty products. Previously, he was the Director of Operations for patient services at Novartis, responsible for all vendors, budgets, and patient services program execution for all Novartis specialty products.

Ilias has also held senior roles on the pricing team at Forest Labs, in trade/channel strategy at Schering Plough, and at Roche on the acute care contracting team and in the patient reimbursement support and assistance department.

Ilias is a licensed pharmacist in the state of New Jersey and, prior to his career in the pharmaceutical industry, worked for over 10 years as a pharmacist, interacting directly with patients, healthcare providers, and third-party insurance organizations in the retail setting at Pathmark Pharmacy, a supermarket pharmacy chain with stores located across the Northeast. Ilias also worked at Medco, a large national Pharmacy Benefit Manager ("PBM"), in its mail-order pharmacy as a staff pharmacist.